These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 12489686)
1. Towards a new age of virtual ADME/TOX and multidimensional drug discovery. Ekins S; Boulanger B; Swaan PW; Hupcey MA J Comput Aided Mol Des; 2002; 16(5-6):381-401. PubMed ID: 12489686 [TBL] [Abstract][Full Text] [Related]
2. Towards a new age of virtual ADME/TOX and multidimensional drug discovery. Ekins S; Boulanger B; Swaan PW; Hupcey MA Mol Divers; 2002; 5(4):255-75. PubMed ID: 12549676 [TBL] [Abstract][Full Text] [Related]
3. Ekins S; Lane TR; Urbina F; Puhl AC Xenobiotica; 2024 Jul; 54(7):352-358. PubMed ID: 37539466 [TBL] [Abstract][Full Text] [Related]
4. Applying machine learning techniques for ADME-Tox prediction: a review. Maltarollo VG; Gertrudes JC; Oliveira PR; Honorio KM Expert Opin Drug Metab Toxicol; 2015 Feb; 11(2):259-71. PubMed ID: 25440524 [TBL] [Abstract][Full Text] [Related]
8. Techniques: application of systems biology to absorption, distribution, metabolism, excretion and toxicity. Ekins S; Nikolsky Y; Nikolskaya T Trends Pharmacol Sci; 2005 Apr; 26(4):202-9. PubMed ID: 15808345 [TBL] [Abstract][Full Text] [Related]
9. In silico ADME/Tox: the state of the art. Ekins S; Rose J J Mol Graph Model; 2002 Jan; 20(4):305-9. PubMed ID: 11858639 [TBL] [Abstract][Full Text] [Related]
10. Predictive Multitask Deep Neural Network Models for ADME-Tox Properties: Learning from Large Data Sets. Wenzel J; Matter H; Schmidt F J Chem Inf Model; 2019 Mar; 59(3):1253-1268. PubMed ID: 30615828 [TBL] [Abstract][Full Text] [Related]
11. ADME-Tox in drug discovery: integration of experimental and computational technologies. Yu H; Adedoyin A Drug Discov Today; 2003 Sep; 8(18):852-61. PubMed ID: 12963322 [TBL] [Abstract][Full Text] [Related]
12. The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox). Szakács G; Váradi A; Ozvegy-Laczka C; Sarkadi B Drug Discov Today; 2008 May; 13(9-10):379-93. PubMed ID: 18468555 [TBL] [Abstract][Full Text] [Related]
13. Improving early drug discovery through ADME modelling: an overview. Wishart DS Drugs R D; 2007; 8(6):349-62. PubMed ID: 17963426 [TBL] [Abstract][Full Text] [Related]
14. In silico ADME/T modelling for rational drug design. Wang Y; Xing J; Xu Y; Zhou N; Peng J; Xiong Z; Liu X; Luo X; Luo C; Chen K; Zheng M; Jiang H Q Rev Biophys; 2015 Nov; 48(4):488-515. PubMed ID: 26328949 [TBL] [Abstract][Full Text] [Related]
15. A model validation and consensus building environment. Abshear T; Banik GM; D'Souza ML; Nedwed K; Peng C SAR QSAR Environ Res; 2006 Jun; 17(3):311-21. PubMed ID: 16815770 [TBL] [Abstract][Full Text] [Related]
16. Present and future in vitro approaches for drug metabolism. Ekins S; Ring BJ; Grace J; McRobie-Belle DJ; Wrighton SA J Pharmacol Toxicol Methods; 2000; 44(1):313-24. PubMed ID: 11274898 [TBL] [Abstract][Full Text] [Related]
17. Evolving molecules using multi-objective optimization: applying to ADME/Tox. Ekins S; Honeycutt JD; Metz JT Drug Discov Today; 2010 Jun; 15(11-12):451-60. PubMed ID: 20438859 [TBL] [Abstract][Full Text] [Related]
18. Metabolic stability for drug discovery and development: pharmacokinetic and biochemical challenges. Masimirembwa CM; Bredberg U; Andersson TB Clin Pharmacokinet; 2003; 42(6):515-28. PubMed ID: 12793837 [TBL] [Abstract][Full Text] [Related]